Skip to content
Open access

Influenza Vaccination Effectiveness in Preventing Hospitalization of Adults With Underlying Medical Conditions: A Multicentre Case–Control Study

Sep 2026 · Influenza and Other Respiratory Viruses · Vol 20 · 0 citations · 42 references
Medicine

TL;DR

The aim was to investigate influenza VE in preventing hospitalization for confirmed influenza among people aged 15–64 years with underlying medical conditions.

Abstract

Seasonal influenza, especially in persons with underlying medical conditions, is a substantial global burden. Influenza vaccination effectiveness (VE) varies annually, requiring continuous evaluation due to evolving viruses and vaccination coverages. Our aim was to investigate influenza VE in preventing hospitalization for confirmed influenza among people aged 15–64 years with underlying medical conditions.

Read PDF

Similar papers

Open access Aug 2026

Establishing a Seasonal Severity Assessment for Respiratory Illness‐ and Influenza‐Associated Hospitalizations in Kenya, 2019–2025

In Kenya, influenza and other respiratory viruses circulate year‐round. The Ministry of Health monitors severe acute respiratory infections (SARI), including influenza‐associated hospitalizations, through a sentinel surveillance network. We developed intensity thresholds (ITs) to assess seasonal severity based on respi...

E. B. White, Jorim Ayugi, Nzisa Liku et al. · 0 citations
Review Open access Sep 2026

Compliance with influenza vaccination recommendations among outpatients with chronic diseases in China in 2022

Influenza vaccination is recommended for people with chronic medical conditions to decrease risk of hospitalization and death from influenza. However, research on compliance with influenza vaccination recommendations among adults with chronic diseases who have an established doctor-patient relation is insufficien...

Hui Xu, Q. Hou, Ya-Chao Jia et al. · 0 citations
Oct 2026

Seasonal influenza vaccination: 2026-2027.

Annual influenza vaccination is recommended for all persons ≥6 months old without a contraindication.1-6 Influenza vaccines available this season in the US are listed in Table 3.

Unknown authors · 0 citations
Review Open access Sep 2026

Comparable burden of severe acute respiratory illness among children and older adults in Kenya: evidence from a multi-site health utilization survey

Highlights • Survey-defined severe respiratory illness was high at both age extremes.• Only 26% of actual admissions in the survey occurred at sentinel hospitals.• The U-shaped age pattern persisted after national geographic extrapolation.• Influenza-associated severe illness was estimated at 365 episodes per 100,000 a...

E. Osoro, Jeanette Dawa, I. Ngere et al. · 0 citations
Open access Sep 2026

Community Incidence of Influenza Virus Infections During Postpandemic Seasons in China, 2022–2025: A Serial Prospective Cohort Study

Following unprecedented disruption of influenza circulation during COVID‐19, concerns arose about postpandemic immunity debt. Community influenza epidemiological and burden data are scarce in mainland China. We estimated influenza incidence in Yancheng (2022–2025) and evaluated protection conferred by preexisting antib...

Hong-Jun Zhang, Jun Guo, Shu-Hui Guan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.